BioLife Solutions
26.80
-0.65
-2.37%
BLFS
10-10 16:00:00(美东时间)
高
27.61
开
27.37
量
35.49万股
总市值
12.84亿
低
26.01
换
0.74%
额
948.43万
市盈TTM
亏损
分时
5日
日K
周K
月K
季K
年K
MA
BOLL
成交量
MACD
KDJ
RSI
WR
BIAS
CCI
PSY
讨论
资讯
公告
资料
财务
相关
成分股
BioLife Solutions(BLFS)
08-22 04:25
$BioLife Solutions(BLFS)$
8-K Current report, item 5.07 Accession Number: 0000834365-25-000018 Act: 34 Size: 157 KB
网页链接
BioLife Solutions(BLFS)
08-22 09:45
$BioLife Solutions(BLFS)$
SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0000919574-25-005054 Act: 34 Size: 26 KB
网页链接
BioLife Solutions(BLFS)
08-29 05:15
$BioLife Solutions(BLFS)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-25-041304 Size: 5 KB
网页链接
BioLife Solutions(BLFS)
09-16 05:05
$BioLife Solutions(BLFS)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001837756-25-000003 Size: 5 KB
网页链接
BioLife Solutions(BLFS)
09-16 04:35
$BioLife Solutions(BLFS)$
144 Report of proposed sale of securities Accession Number: 0001950047-25-007137 Act: 33 Size: 7 KB
网页链接
BioLife Solutions(BLFS)
09-16 05:05
$BioLife Solutions(BLFS)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001556355-25-000003 Size: 5 KB
网页链接
BioLife Solutions(BLFS)
08-29 05:15
$BioLife Solutions(BLFS)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-25-041301 Size: 5 KB
网页链接
BioLife Solutions(BLFS)
08-14 07:05
$BioLife Solutions(BLFS)$
SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0000919574-25-004704 Act: 34 Size: 26 KB
网页链接
BioLife Solutions(BLFS)
08-15 00:15
$BioLife Solutions(BLFS)$
SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001897612-25-000347 Act: 34 Size: 7 KB
网页链接
BioLife Solutions(BLFS)
08-29 05:15
$BioLife Solutions(BLFS)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-25-041300 Size: 5 KB
网页链接
BioLife Solutions(BLFS)
08-29 05:15
$BioLife Solutions(BLFS)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-25-041303 Size: 5 KB
网页链接
BioLife Solutions(BLFS)
08-29 05:15
$BioLife Solutions(BLFS)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-25-041302 Size: 5 KB
网页链接
BioLife Solutions(BLFS)
08-12 09:25
$BioLife Solutions(BLFS)$
144 Report of proposed sale of securities Accession Number: 0000919574-25-004448 Act: 33 Size: 5 KB
网页链接
BioLife Solutions(BLFS)
08-22 09:15
$BioLife Solutions(BLFS)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0000919574-25-005051 Size: 11 KB
网页链接
BioLife Solutions(BLFS)
09-16 05:05
$BioLife Solutions(BLFS)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0002047541-25-000003 Size: 5 KB
网页链接
BioLife Solutions(BLFS)
08-26 04:45
$BioLife Solutions(BLFS)$
144 Report of proposed sale of securities Accession Number: 0001950047-25-006348 Act: 33 Size: 5 KB
网页链接
BioLife Solutions(BLFS)
08-29 05:15
$BioLife Solutions(BLFS)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-25-041299 Size: 5 KB
网页链接
BioLife Solutions(BLFS)
08-16 09:35
$BioLife Solutions(BLFS)$
144 Report of proposed sale of securities Accession Number: 0000919574-25-004980 Act: 33 Size: 7 KB
网页链接
BioLife Solutions(BLFS)
08-14 06:45
$BioLife Solutions(BLFS)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0000919574-25-004702 Size: 10 KB
网页链接
MedaketCopilot
08-21 22:04
BioLife Solutions 宣布对西雅图 iPSC 企业 Pluristyx 进行战略性投资,以可转债形式购入 200 万美元份额,并取得董事会观察员席位及未来潜在并购相关权利,此项投资作为 Pluristyx 本轮融资的一部分,旨在加速 Pluristyx 的产品量产与商业化布局并深化双方在生物检测与类器官制造的协同。
Plu...